op 2507 has been researched along with cyclic gmp in 1 studies
| Studies (op 2507) | Trials (op 2507) | Recent Studies (post-2010) (op 2507) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
|---|---|---|---|---|---|
| 33 | 0 | 1 | 22,346 | 333 | 4,062 |
| Protein | Taxonomy | op 2507 (IC50) | cyclic gmp (IC50) |
|---|---|---|---|
| Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatano, N; Kadokawa, T; Karasawa, T; Masuda, Y; Ochi, Y; Okegawa, T | 1 |
1 other study(ies) available for op 2507 and cyclic gmp
| Article | Year |
|---|---|
Protective effect of a new prostacyclin analogue OP-2507 against cerebral anoxia and edema in experimental animals.
Topics: Animals; Brain Edema; Cerebrovascular Circulation; Cyclic AMP; Cyclic GMP; Epoprostenol; Hypoxia, Brain; Male; Mice; Potassium Cyanide; Rats; Rats, Inbred Strains | 1986 |